INTERINDIVIDUAL VARIATION IN HALF-LIFE OF INFUSED RECOMBINANT FACTOR-VIII IS RELATED TO PRE-INFUSION VON-WILLEBRAND-FACTOR ANTIGEN LEVELS

被引:96
作者
FIJNVANDRAAT, K [1 ]
PETERS, M [1 ]
TENCATE, JW [1 ]
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,CTR HAEMOSTASIS THROMBOSIS ATHEROSCLEROSIS & INFL,1100 DE AMSTERDAM,NETHERLANDS
关键词
FACTOR VIII; HEMOPHILIA A; VON WILLEBRAND FACTOR; PHARMACOKINETICS; RECOMBINANT;
D O I
10.1111/j.1365-2141.1995.tb05325.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In an attempt to explain the substantial interindividual variability in half-life of infused factor VIII (FVIII) among haemophilia A patients, we studied the correlation of pre-infusion von Willebrand factor antigen (vWFAg) levels and the half-life of a recombinant-DNA-derived FVIII (r-VIII SQ, Pharmacia, Sweden). Intra-individual variation in half-life was small (range of variation 0-2.1 h) in 12 severely affected haemophiliacs who received two doses of FVIII concentrate. In contrast, inter-individual variation in half-life was large (range of half-lives 6-28.8 h). A strong correlation between half-life and pre-infusion vWFAg levels was present (r = 0.87, P = 0.0003). We conclude that the half-life of infused recombinant FVIII is related to preinfusion vWFAg levels in severely affected haemophilia A patients.
引用
收藏
页码:474 / 476
页数:3
相关论文
共 10 条
[1]  
CARLSSON N, 1993, EUR J HAEMATOL, V51, P247
[2]   PATIENTS WITH SEVERE VON-WILLEBRAND DISEASE ARE INSENSITIVE TO THE RELEASING EFFECT OF DDAVP - EVIDENCE THAT THE DDAVP-INDUCED INCREASE IN PLASMA FACTOR-VIII IS NOT SECONDARY TO THE INCREASE IN PLASMA VON-WILLEBRAND-FACTOR [J].
CATTANEO, M ;
SIMONI, L ;
GRINGERI, A ;
MANNUCCI, PM .
BRITISH JOURNAL OF HAEMATOLOGY, 1994, 86 (02) :333-337
[3]   CHARACTERIZATION OF HUMAN FACTOR-VIII AND INTERACTION WITH VONWILLEBRAND-FACTOR - AN ELECTRON-MICROSCOPIC STUDY [J].
HEIJNEN, HFG ;
KOEDAM, JA ;
SANDBERG, H ;
BEESERVISSER, NH ;
SLOT, JW ;
SIXMA, JJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1990, 194 (02) :491-498
[4]  
HELLSTERN P, 1986, THROMB HAEMOSTASIS, V56, P353
[5]   THE INTERACTION BETWEEN HUMAN BLOOD-COAGULATION FACTOR-VIII AND VONWILLEBRAND-FACTOR - CHARACTERIZATION OF A HIGH-AFFINITY BINDING-SITE ON FACTOR-VIII [J].
LEYTE, A ;
VERBEET, MP ;
BRODNIEWICZPROBA, T ;
VANMOURIK, JA ;
MERTENS, K .
BIOCHEMICAL JOURNAL, 1989, 257 (03) :679-683
[6]   MULTI-VARIATE ANALYSIS OF FACTORS GOVERNING THE PHARMACOKINETICS OF EXOGENOUS FACTOR-VIII IN HEMOPHILIACS [J].
MESSORI, A ;
LONGO, G ;
MORFINI, M ;
CINOTTI, S ;
FILIMBERTI, E ;
GIUSTARINI, G ;
FERRINI, PR .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1988, 35 (06) :663-668
[7]   CLINICAL PHARMACOKINETICS OF FACTOR-VIII IN PATIENTS WITH CLASSIC HEMOPHILIA [J].
MESSORI, A ;
LONGO, G ;
MATUCCI, M ;
MORFINI, M ;
FERRINI, PLR .
CLINICAL PHARMACOKINETICS, 1987, 13 (06) :365-380
[8]  
MORFINI M, 1991, THROMB HAEMOSTASIS, V66, P384
[9]  
MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270
[10]  
SANDBERG H, 1994, 21 INT C WORLD FED H, P106